J. Prawjaeng

Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis

P. Narongroeknawin, W. Katchamart, N. Budtarad, 2023, medRxiv.

Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines

W. Pan-ngum, H. Wee, H. Clapham, 2021, Applied Health Economics and Health Policy.

Advocating evidence-informed policy in Thailand: The case of the development of bicycle commuting policy framework

K. Kantamaturapoj, J. Yothasamut, Pattara Leelahavarong, 2022, Case Studies on Transport Policy.

Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in a Malaysian population

W. Tassaneeyakul, Z. Mohamed, N. Chaiyakunapruk, 2017, Pharmacogenetics and genomics.

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic

W. Pan-ngum, Y. Teerawattananon, W. Isaranuwatchai, 2022, The European Journal of Health Economics.

Optimal vaccine strategy to control COVID-19 pandemic in middle-income countries: Modelling case study of Thailand

R. Águas, L. White, W. Pan-ngum, 2021 .

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity

P. Narongroeknawin, W. Katchamart, N. Budtarad, 2023, BMC Health Services Research.

A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand

Y. Teerawattananon, E. Barasa, A. Kairu, 2022, International journal of public health.

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic

W. Pan-ngum, Y. Teerawattananon, W. Isaranuwatchai, 2022, European Journal of Health Economics.